UPDATE: Arcturus Therapeutics (ARCT) PT Lowered to $16 at Goldman Sachs
Tweet Send to a Friend
(Updated - March 1, 2022 7:40 AM EST)
Goldman Sachs analyst Madhu Kumar lowered the price target on Arcturus ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Goldman Sachs analyst Madhu Kumar lowered the price target on Arcturus ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE